TrialClinical interventions in aging2025

Denosumab for Primary Osteoporosis and Its Impact on Sarcopenia in the Chinese Population: Insights from Clinical Evidence and RANKL Pathway Mendelian Randomization.

Shaotian Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.